Akums Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 ,inter alia, to consider and approve Un-audited ....
AKUMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Akums Drugs and Pharmaceuticals has informed the exchanges that its Board of Directors will meet on Monday, 26th May 2025. The agenda includes approving the Un-audited Standalone and Consolidated Financial Results for Q4FY25 (quarter ended 31st March 2025) and the Audited Standalone and Consolidated Financial Statements for FY25 (year ended 31st March 2025). This is a routine SEBI LODR Regulation 29 compliance filing and does not contain any actual financial numbers. The meeting will clear both the Q4 quarterly numbers and the full-year audited accounts on the same day.
No immediate impact on shareholders or stock price — this is just a notice ahead of results. Investors should watch for the actual Q4 and FY25 numbers on 26th May for any earnings surprise or directional signal.